Literature DB >> 325150

Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.

C J Utz, S Shadomy.   

Abstract

The susceptibilities of 216 isolates of pathogenic and commensal yeasts to 5-fluorocytosine were tested by a disk diffusion technique with use of 1- and 10-microgram disks. Minimal inhibitory concentrations (MICs) were determined by an agar dilution procedure with yeast morphology agar, pH 5.0, supplemented with 0.25 mg of thiamine/dl. Zones of inhibition produced by the two disks were correlated with paired MIC values. An MIC of 16 micrograms/ml, the upper limit of probable clinical susceptibility, correlated with zones of 14 mm and 25 mm, respectively, for the 1- and 10-microgram disks. With these values as interpretative breakpoints, the 1-microgram disk would have failed to predict clinical susceptibility with 25% of the suceptible isolates of Candida species other than Candida albicans, with 14% of the susceptible isolates of Cryptococcus neoformans, with 7% of the susceptible isolates of C. albicans, and with one of the 25 susceptible isolates of Torulopsis glabrata. The 10-microgram disk would have failed to predict susceptibility with only two isolates of Candida species.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 325150     DOI: 10.1093/infdis/135.6.970

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Ketoconazole resistance in Torulopsis glabrata.

Authors:  G Nobre; E Mendes; M J Charrua; O Cruz
Journal:  Mycopathologia       Date:  1989-07       Impact factor: 2.574

Review 2.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 3.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

4.  Evaluation of five commercial antifungal susceptibility testing systems.

Authors:  A Druetta; A Freydiere; R Guinet; Y Gille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

5.  A microautomated dilution method for susceptibility testing with antifungal drugs.

Authors:  L Polonelli; G Morace
Journal:  Mycopathologia       Date:  1984-04-30       Impact factor: 2.574

6.  Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.

Authors:  R L Stiller; J E Bennett; H J Scholer; M Wall; A Polak; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

7.  Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.

Authors:  D L Calhoun; G D Roberts; J N Galgiani; J E Bennett; D S Feingold; J Jorgensen; G S Kobayashi; S Shadomy
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

Review 8.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  Disk agar diffusion susceptibility testing of yeasts.

Authors:  M A Saubolle; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

10.  Antimicrobial activities of hexane extract and decussatin from stembark extract of Ficus congensis.

Authors:  Chinwendum Stephenie Alaribe; Francis Shode; Herbert A B Coker; Gloria Ayoola; Adesegun Sunday; Nisha Singh; Silva Iwuanyanwu
Journal:  Int J Mol Sci       Date:  2011-04-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.